Searcharxiv⌕ Search

arXiv subjects

R Yadunandan

Publications and source records attributed to R Yadunandan.

2 recordsLinked to original sources

MT-RGCN-DTI: A Multi-Task Relational Graph Convolutional Network for Drug-Target Interaction Prediction

Prediction of drug-target interaction (DTI) has become a very crucial part of drug discovery. With the increase in the data volume, it has become very important to improve prediction accuracy by integrating multiple data sources. In this regard, utilising multiple resources in the form of heterogeneous information network to address DTI prediction can be rewarding. In this work, we propose a heterogeneous information network based multi-task DTI prediction model which leverages the advantages of relation graph convolutional network (RGCN). To achieve this, the model employs drug-target interaction network, drug-drug similarity network and protein-protein similarity network to construct a heterogeneous information network. Moreover, we use a knowledge graph embedding scoring functions to model interactions between drug and targets, specifically DistMult and ComplEx as decoders over the learned node representations. We performed extensive experiments on multiple benchmark datasets and compared with state-of-the-art methods. We observed that the proposed model shows competitive performance, thereby confirming the effectiveness of our approach. The codes and datasets are available at https://github.com/Dheeran-S/MT-RGCN-DTI/.

cs.LG↗

ReACT-Drug: Reaction-Template Guided Reinforcement Learning for de novo Drug Design

De novo drug design is a crucial component of modern drug development, yet navigating the vast chemical space to find synthetically accessible, high-affinity candidates remains a significant challenge. Reinforcement Learning (RL) enhances this process by enabling multi-objective optimization and exploration of novel chemical space - capabilities that traditional supervised learning methods lack. In this work, we introduce \textbf{ReACT-Drug}, a fully integrated, target-agnostic molecular design framework based on Reinforcement Learning. Unlike models requiring target-specific fine-tuning, ReACT-Drug utilizes a generalist approach by leveraging ESM-2 protein embeddings to identify similar proteins for a given target from a knowledge base such as Protein Data Base (PDB). Thereafter, the known drug ligands corresponding to such proteins are decomposed to initialize a fragment-based search space, biasing the agent towards biologically relevant subspaces. For each such fragment, the pipeline employs a Proximal Policy Optimization (PPO) agent guiding a ChemBERTa-encoded molecule through a dynamic action space of chemically valid, reaction-template-based transformations. This results in the generation of \textit{de novo} drug candidates with competitive binding affinities and high synthetic accessibility, while ensuring 100\% chemical validity and novelty as per MOSES benchmarking. This architecture highlights the potential of integrating structural biology, deep representation learning, and chemical synthesis rules to automate and accelerate rational drug design. The dataset and code are available at https://github.com/YadunandanRaman/ReACT-Drug/.

cs.LG↗